MXPA05011620A - Dispositivos medicos y metodos para inhibir la proliferacion de celulas de musculo liso. - Google Patents
Dispositivos medicos y metodos para inhibir la proliferacion de celulas de musculo liso.Info
- Publication number
- MXPA05011620A MXPA05011620A MXPA05011620A MXPA05011620A MXPA05011620A MX PA05011620 A MXPA05011620 A MX PA05011620A MX PA05011620 A MXPA05011620 A MX PA05011620A MX PA05011620 A MXPA05011620 A MX PA05011620A MX PA05011620 A MXPA05011620 A MX PA05011620A
- Authority
- MX
- Mexico
- Prior art keywords
- smooth muscle
- muscle cells
- inhibiting proliferation
- methods
- medical devices
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/15—Depsipeptides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/432—Inhibitors, antagonists
- A61L2300/434—Inhibitors, antagonists of enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
- A61L2300/604—Biodegradation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invencion proporciona inhibidores de histona desacetilasa para usarse para inhibir la proliferacion y/o migracion de celulas de musculo suave. La presente invencion ademas proporciona dispositivos medicos recubiertos con los inhibidores de histona desacetilasa. La presente invencion tambien proporciona el uso de dispositivos medicos en metodos para inhibir la proliferacion y/o la migracion de celulas de musculo suave. Adicionalmente, la presente invencion proporciona metodos para inhibir la proliferacion y/o la migracion de celulas de musculo suave no neoplasticas. Finalmente, la presente invencion proporciona metodos para evitar o tratar la re-estenosis despues de la angioplastia o implantacion de molde en un sujeto.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/425,354 US20040213826A1 (en) | 2003-04-28 | 2003-04-28 | Medical devices and methods for inhibiting proliferation of smooth muscle cells |
PCT/US2004/011757 WO2004098495A2 (en) | 2003-04-28 | 2004-04-16 | Medical devices and methods for inhibiting proliferation of smooth muscle cells |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05011620A true MXPA05011620A (es) | 2005-12-15 |
Family
ID=33299494
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05011620A MXPA05011620A (es) | 2003-04-28 | 2004-04-16 | Dispositivos medicos y metodos para inhibir la proliferacion de celulas de musculo liso. |
Country Status (4)
Country | Link |
---|---|
US (1) | US20040213826A1 (es) |
CA (1) | CA2524166A1 (es) |
MX (1) | MXPA05011620A (es) |
WO (1) | WO2004098495A2 (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7399480B2 (en) | 1997-09-26 | 2008-07-15 | Abbott Laboratories | Methods of administering tetrazole-containing rapamycin analogs with other therapeutic substances using medical devices |
US8747881B2 (en) * | 2003-12-19 | 2014-06-10 | Cordis Corporation | Intraluminal medical devices in combination with therapeutic agents |
US8652502B2 (en) * | 2003-12-19 | 2014-02-18 | Cordis Corporation | Local vascular delivery of trichostatin A alone or in combination with sirolimus to prevent restenosis following vascular injury |
US20050220835A1 (en) * | 2004-03-30 | 2005-10-06 | Jayaraman Ramesh B | Agent eluting bioimplantable devices and polymer systems for their preparation |
CA2600924A1 (en) * | 2005-03-09 | 2006-09-21 | Lisa K. Jennings | Barrier stent and use thereof |
EP1904452A2 (en) | 2005-07-14 | 2008-04-02 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
US7301403B2 (en) * | 2005-09-10 | 2007-11-27 | Comlent Technology, Inc. | Low noise amplifier with switch gain control |
US20100137239A1 (en) | 2006-04-24 | 2010-06-03 | Gloucester Pharmaceuticals | Gemcitabine combination therapy |
US8957027B2 (en) | 2006-06-08 | 2015-02-17 | Celgene Corporation | Deacetylase inhibitor therapy |
CN101801994A (zh) | 2006-12-29 | 2010-08-11 | 格洛斯特制药公司 | 制备Romidepsin |
MY185130A (en) | 2010-07-12 | 2021-04-30 | Celgene Corp | Romidepsin solid forms and uses thereof |
US8859502B2 (en) | 2010-09-13 | 2014-10-14 | Celgene Corporation | Therapy for MLL-rearranged leukemia |
WO2013091722A1 (en) * | 2011-12-23 | 2013-06-27 | Innora Gmbh | Drug-coated medical devices |
AU2013202506B2 (en) | 2012-09-07 | 2015-06-18 | Celgene Corporation | Resistance biomarkers for hdac inhibitors |
AU2013202507B9 (en) | 2012-11-14 | 2015-08-13 | Celgene Corporation | Inhibition of drug resistant cancer cells |
NZ630311A (en) | 2013-12-27 | 2016-03-31 | Celgene Corp | Romidepsin formulations and uses thereof |
CN117427227B (zh) * | 2023-10-25 | 2024-06-11 | 中国人民解放军北部战区总医院 | Epsin1-Epsin2-shRNA功能基因涂层支架及制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5464395A (en) * | 1994-04-05 | 1995-11-07 | Faxon; David P. | Catheter for delivering therapeutic and/or diagnostic agents to the tissue surrounding a bodily passageway |
US5788979A (en) * | 1994-07-22 | 1998-08-04 | Inflow Dynamics Inc. | Biodegradable coating with inhibitory properties for application to biocompatible materials |
US7220275B2 (en) * | 1996-11-04 | 2007-05-22 | Advanced Stent Technologies, Inc. | Stent with protruding branch portion for bifurcated vessels |
US5871437A (en) * | 1996-12-10 | 1999-02-16 | Inflow Dynamics, Inc. | Radioactive stent for treating blood vessels to prevent restenosis |
US5897911A (en) * | 1997-08-11 | 1999-04-27 | Advanced Cardiovascular Systems, Inc. | Polymer-coated stent structure |
US20020005206A1 (en) * | 2000-05-19 | 2002-01-17 | Robert Falotico | Antiproliferative drug and delivery device |
-
2003
- 2003-04-28 US US10/425,354 patent/US20040213826A1/en not_active Abandoned
-
2004
- 2004-04-16 MX MXPA05011620A patent/MXPA05011620A/es unknown
- 2004-04-16 WO PCT/US2004/011757 patent/WO2004098495A2/en active Application Filing
- 2004-04-16 CA CA002524166A patent/CA2524166A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20040213826A1 (en) | 2004-10-28 |
WO2004098495A2 (en) | 2004-11-18 |
WO2004098495A3 (en) | 2005-03-24 |
CA2524166A1 (en) | 2004-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA05011620A (es) | Dispositivos medicos y metodos para inhibir la proliferacion de celulas de musculo liso. | |
WO2004060318A3 (en) | Drug-coated stents and methods of use therefor | |
ATE448812T1 (de) | Beschichtung von stents mit verzögerter wirkstofffreisetzung | |
EP1648339A4 (en) | IMPLANTABLE PROSTHESES, PARTICULARLY FOR TRANSARTERIAL APPLICATION FOR THE TREATMENT OF AORTIC STENOSIS AND METHODS FOR IMPLANTATION OF SAID PROSTHESES | |
ATE420675T1 (de) | Mit 40-o-(2-hydroxy)ethyl-rapamycin beschichteter stent | |
WO2004075781A3 (en) | Bioactive stents and methods for use thereof | |
AU2003298880A1 (en) | Coating for implantable devices and a method of forming the same | |
ATE448813T1 (de) | Angiotensin-(1-7) freisetzende polymerbeschichtete medizinische vorrichtung zur reduzierung von restenose und zur verbesserung von endothelzellfunktionen | |
ATE451130T1 (de) | Phospholipid und verunreinigungsbeständige beschichtungszusammensetzungen | |
DE10294792D2 (de) | Beschichtung von Stents zur Verhinderung von Restenose | |
MX2009012766A (es) | Stent absorbible con un recubrimiento para controlar la degradacion del stent y mantener la neutralidad del ph. | |
EP1830745A4 (en) | IMPLANTABLE SYSTEMS AND STENTS CONTAINING CELLS FOR THERAPEUTIC USE | |
ATE469615T1 (de) | Künstliches, vaskuläres transplantat sowie verfahren zu seiner herstellung und seinem gebrauch | |
ATE423578T1 (de) | Medizinprodukt mit einem biologischen wirkstoff | |
DK0786991T3 (da) | Polyaminforbindelsre til behandling af proliferative karsygdomme | |
ATE453416T1 (de) | Medizinischer stent mit einer kombination aus melatonin und paclitaxel | |
WO2004009771A3 (en) | Stents capable of controllably releasing histone deacetylase inhibitors | |
WO2003103743A3 (en) | MEDICAL DEVICE FOR INTRALUMINAL SUPPLY OF PHARMACEUTICAL AGENTS | |
ATE438361T1 (de) | Stent beschichtet mit dna | |
UA88655C2 (ru) | S-миртазапин для лечения прилива крови | |
WO2010042343A3 (en) | Combination local delivery using a stent | |
WO2003061597A3 (en) | Use of inhibitors of soluble epoxide hydrolase to inhibit vascular smooth muscle cell proliferation | |
WO2003059192A3 (en) | C3 exoenzyme-coated stents and uses thereof for treating and preventing restenosis | |
DE602007009045D1 (de) | Zein-beschichtete medizinische vorrichtung | |
WO2007062036A3 (en) | Implantable medical device coatings with biodegradable elastomer and releasable therapeutic agent |